Referral (article 31): LEUPRORELIN-containing depot medicinal products, LEUPRORELIN. Review of handling errors.

14 juin 2019

BlueRegWatch

EMA has started a procedure for the review of leuprorelin medicines after reports indicated that handling errors with the products during preparation and administration can cause some patients to receive insufficient amounts of their medicine, thus reducing the benefits of treatment.

BlueRegWatch

Vous avez aimé cet article ? Partagez le sur les réseaux sociaux :

Découvrez notre dernier livre blanc

En savoir plus